Sun Pharma can touch Rs 508: Ashish Chaturmohta

Sun Pharma Can touch Rs 508, says Ashish Chaturmohta of IIFL Wealth.

Chaturmohta told CNBC-Awaaz, "Investors should buy Sun Pharma with a stoploss of Rs 478. The stock is looking good on chart. It can touch Rs 508 in next 2-4 days time."
The company's trailing 12-month (TTM) EPS was at Rs 14.33 per share. (Jun 2011). The stock's price-to-earnings (P/E) ratio was 34.06. The latest book value of the company is Rs 64.51 per share. At current value, the price-to-book value of the company was 7.57. The dividend yield of the company was 0.72%.